Neural mechanisms in human obesity-related hypertension

Journal of Hypertension

Volumn 17, Issue 8, 1999, Pages 1125-1133

  Rumantir, Magdalena S ^a   Vaz, Mario ^a   Jennings, Garry L ^a   Collier, Greg ^b   Kaye, David M ^a   Seals, Douglas R ^c   Wiesner, Glen H ^a   Brunner La Rocca, Hans P ^a   Esler, Murray D ^a,d  

^a ALFRED HOSPITAL   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF COLORADO   (United States)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Adrenaline; Heart; Kidneys; Leptin; Noradrenaline; Obesity; Sympathetic nervous system

Indexed keywords

ISOTOPE; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; HEART; HEART RATE; HUMAN; HYPERTENSION; HYPOTHESIS; KIDNEY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; METABOLISM; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; SYMPATHETIC TONE; WEIGHT GAIN;

EID: 0032796681     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917080-00012     Document Type: Article

References (46)

1. 1 Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 1978; 298:1295-1301.
2. 2 Bray GA, York DA, Fisler JS. Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam Horm 1989; 45:1-125.
3. 3 Jung RT, Shetty PS, James WPT. The effect of beta-adrenergic blockade on resting metabolic rate and peripheral thyroid metabolism in obesity. Eur J Clin Invest 1980; 10:179-182.
4. 4 Bielinski R, Schutz Y, Jequier E. Energy metabolism during postexercise recovery in man. Am J Clin Nutr 1985; 42:69-82.
5. 5 Schwartz RS, Jaeger LF, Veith RC. Effect of clonidine on the thermic effect of feeding in humans. Am J Physiol 1988; 254:R90-R94.
6. 6 Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92:1730-1735.
7. 7 Bazelmans J, Nestel P, O'Dea K, Esler M. Blunted norepinephrine responsiveness to changing energy states in obese subjects. Metabolism 1985; 34:154-160.
8. 8 Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lamfranchi A, Colombo M, et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25:560-563.
9. 9 Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96:3423-3429.
10. 10 Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. QJ Med 1986; 236:1081-1090.
11. 11 Bjorntorp P. Visceral fat accumulation, the missing link between psychosocial factors and cardiovascular disease? J Int Med 1991; 230:195-202.
12. 12 Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans Am J Physiol 1984; 247:E21-E28.
13. 13 Esler MD, Kaye DM, Thompson JM, Jennings GL, Cox HS, Turner AG, et al. Effects of aging on epinephrine secretion, and on regional release of epinephrine from the human heart. J Clin Endocrinol Metab 1995; 80:435-442.
14. 14 Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 1990; 70:963-985.
15. 15 Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G. Simultaneous determination of plasma noradrenaline and adrenaline kinetics: responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 1990; 341:192-199.
16. 16 Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension 1997; 30:619-623.
17. 17 Rosenbaum M, Nicholson M, Hirsch J, Hoymsfield SB, Gallagher D, Chu F, et al. Effects of gonder, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81:3424-3427.
18. 18 Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1989; 14:177-183.
19. 19 Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 1998; 31:64-67.
20. 20 Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, et al. The assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988; 11:3-20.
21. 21 Rostrup M, Mundal HH, Kjeldsen SE, Eide I. Awareness of high blood pressure increases arterial plasma catecholamines, platelet norepinephrine and adrenergic responses to mental stress. J Hypertens 1991; 9:159-166.
22. 22 Thompson JM, Jennings GL, Chin JPF, Esler MD. Measurement of human sympathetic nervous responses to stressors by microneurography. J Autonom Nerv Syst 1994; 49:277-281.
23. 23 Folkow B, Di Bona GF, Hjemdahl P, Thoren PH, Wallin BG. Measurement of plasma norepinephrine concentrations in primary hypertension: a word of caution on their applicability for assessing neurogenic contributions. Hypertension 1983; 5:399-402.
24. 24 Christin L, O'Connell M, Bogardus E, Danforth E, Ravussin E. Norepinephrine turnover and energy expenditure in Pima Indian and white men. Metabolism 1993; 42:723-729.
25. 25 Poehlman ET, Gardner AW, Goran MI, Arciero PJ, Toth MJ, Ades PA, et al. Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males. J Appl Physiol 1995; 78:802-806.
26. 26 Narkiewicz K, van de Borne PJH, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnoea. Circulation 1998; 98:772-776.
27. 27 Levin BE. Reduced norepinephrine turnover in organs and brains of obesity prone rats. Am J Physiol 1995; 268:R389-R394.
28. 28 Jones PP, Davy KP, Seals DR. Relations of total and abdominal obesity to muscle sympathetic nerve activity in healthy older males. Int J Obes Relat Metab Disord 1997; 21:1053-1057.
29. 29 Cox HS, Kaye DM, Thompson JM, Turner AG, Jennings GL, Itsiopoulos C, et al. Regional sympathetic nervous activation after a large meal in humans. Clin Sci 1995; 89:145-154.
30. 30 Landsberg L. Hyperinsulinemia: possible role in obesity-induced hypertension. Hypertension 1992; 19 (suppl):161-166.
31. 31 Vollenmeider P, Tappy L, Randin D, Schneiler P, Jequier E, Nicod P, et al. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 1993; 92:147-154.
32. 32 Baskin DG, Figlewicz DP, Woods SC, Porte Jr D, Dorsa DM. Insulin in the brain. Ann Rev Physiol 1987; 49:335-347.
33. 33 Gudbjornsdottir S, Friberg P, Elam M, Attvall S, Lonnroth P, Wallin BG. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men. Blood Press 1994; 3:394-403.
34. 34 Lindpainter K. Finding an obesity gene - a tale of mice and men. N Engl J Med 1995; 332:679-680.
35. 35 Mazuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al. Non-adipose tissue production of leptin: leptin as a novel placental derived hormone in humans. Nature Med 1997; 3:1029-1033.
36. 36 Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L. A nutrient sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998; 393:684-688.
37. 37 Esler M, Vaz M, Collier G, Nestel P, Jennings G, Kaye D, et al. Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet 1998; 351:879.
38. 38 Di Bona GF. Sympathetic neural control of the kidney in hypertension. Hypertension 1992; 19:128-135.
39. 39 Messerli FH, Sundgaard-Riise K, Reisin E, Dreslinski G, Dunn FG, Frohlich E. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 1983; 74:808-812.
40. 40 Sjostrom L. Morbidity and mortality of severely obese subjects. Am J Clin Nutr 1992; 55:508S-515S.
41. 41 Hall JE, Brands MW, Hildebrandt DA, Mizello HL. Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms. Hypertension 1992; 19:145-155.
42. 42 Rocchini AP, Moorehead C, DeRemer S, Bondie D. Pathogenesis of weight-related changes in blood pressure in dogs. Hypertension 1989; 13:922-928.
43. 43 Schobel HP, Fischer T, Langenfeld M, Schmieder RE. Pregnancy induced hypertension: a state of sympathetic overactivity [abstract]. Circulation 1995; 92:1421.
44. 44 O'Dea K, Esler M, Leonard P, Stockigt J, Nestel P. Noradrenaline turnover during under-and over-eating in normal weight subjects. Metabolism 1982; 31:896-899.
45. 45 Meredith IT, Friberg P, Jennings GL, Dewar EM, Fazio VA, Lambert GW, et al. Regular exercise lowers renal but not cardiac sympathetic activity in man. Hypertension 1991; 18:575-582.
46. 46 Dengel DR, Hagberg J, Pratley RE, Rogus EM, Goldberg AP. Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men. Metabolism 1998; 47:1075-1082.